Some 920 applications have been filed in the United Kingdom for compensation related to injuries and deaths of people following COVID-19 vaccinations. Those applications are for financial payouts under the U.K. National Health Service’s (NHS) Vaccine Damage Payment Scheme (VDPS), which allows an individual who has allegedly been left severely disabled by a vaccine to […]
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]
As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, […]
A 36-year-old man in Madison County, Tennessee died unexpectedly on Sept. 25, 2021, three days after receiving the second dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. Timothy Adam Hornsby was vaccinated on Sept. 22 and started feeling ill the next morning. His health took a turn for the worse two days […]
Opinion | As one-size-fits-all COVID vaccine mandates sweep government, academia, and corporate America, new data are emerging that undermine the public health justifications for these policies. Studies from multiple countries now indicate that vaccination alone is less effective than the acquired immunity many already possess and unable to prevent transmission in the medium-to-long term. Since the pandemic began, more […]
The European Medicines Agency (EMA) last week added an autoimmune condition known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information on AstraZeneca/Oxford University’s Vaxzevria (or “AZD1222”) experimental adenovirus vectored vaccine. GBS is a neurological disorder that causes pain, numbness, muscle weakness and sometimes paralysis.1 2 3 4 A total of […]
Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]
A new poll conducted Yahoo! News/YouGov during July 13-15, 2021 found that 37 percent of unvaccinated Americans are more fearful of the three experimental COVID-19 biologics currently available in the United States than they are of the SARS-CoV-2 virus that can cause the disease. The survey of 1,715 adults in the U.S. found that only […]
A recent study published by King’s College in London, which operates the ZOE COVID Study app to monitor COVID infection and vaccination rates, found that, as of July 15, 2021, there was an average of 15,537 new daily symptomatic cases of COVID-19 among partly or fully vaccinated people in the United Kingdom—an increase of 40 […]